5dkn
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ''' | + | ==Crystal Structure of Calcium-loaded S100B bound to SBi4225== |
| + | <StructureSection load='5dkn' size='340' side='right' caption='[[5dkn]], [[Resolution|resolution]] 1.53Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[5dkn]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5DKN OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5DKN FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=B7I:2,2-[HEPTANE-1,7-DIYLBIS(OXYBENZENE-4,1-DIYL)]BIS(1H-IMIDAZOLE)'>B7I</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene></td></tr> | ||
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5dkq|5dkq]], [[5dkr|5dkr]]</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5dkn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5dkn OCA], [http://pdbe.org/5dkn PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5dkn RCSB], [http://www.ebi.ac.uk/pdbsum/5dkn PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/S100B_BOVIN S100B_BOVIN]] Weakly binds calcium but binds zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Physiological concentrations of potassium ion antagonize the binding of both divalent cations, especially affecting high-affinity calcium-binding sites. Binds to and initiates the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization (By similarity).<ref>PMID:14661952</ref> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The drug pentamidine inhibits calcium-dependent complex formation with p53 (CaS100B.p53) in malignant melanoma (MM) and restores p53 tumor suppressor activity in vivo. However, off-target effects associated with this drug were problematic in MM patients. Structure-activity relationship (SAR) studies were therefore completed here with 23 pentamidine analogues, and X-ray structures of CaS100B.inhibitor complexes revealed that the C-terminus of S100B adopts two different conformations, with location of Phe87 and Phe88 being the distinguishing feature and termed the "FF-gate". For symmetric pentamidine analogues (CaS100B.5a, CaS100B.6b) a channel between sites 1 and 2 on S100B was occluded by residue Phe88, but for an asymmetric pentamidine analogue (CaS100B.17), this same channel was open. The CaS100B.17 structure illustrates, for the first time, a pentamidine analog capable of binding the "open" form of the "FF-gate" and provides a means to block all three "hot spots" on CaS100B, which will impact next generation CaS100B.p53 inhibitor design. | ||
| - | + | Small Molecule Inhibitors of Ca-S100B Reveal Two Protein Conformations.,Cavalier MC, Ansari MI, Pierce AD, Wilder PT, McKnight LE, Raman EP, Neau DB, Bezawada P, Alasady MJ, Charpentier TH, Varney KM, Toth EA, MacKerell AD Jr, Coop A, Weber DJ J Med Chem. 2016 Jan 13. PMID:26727270<ref>PMID:26727270</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | <div class="pdbe-citations 5dkn" style="background-color:#fffaf0;"></div> | |
| - | [[Category: | + | == References == |
| - | [[Category: | + | <references/> |
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Alasady, M J]] | ||
| + | [[Category: Ansari, M I]] | ||
[[Category: Bezawada, P]] | [[Category: Bezawada, P]] | ||
| - | [[Category: | + | [[Category: Cavalier, M C]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
[[Category: Coop, A]] | [[Category: Coop, A]] | ||
| - | [[Category: | + | [[Category: MacKerell, A D]] |
| - | [[Category: | + | [[Category: McKnight, L E]] |
| - | [[Category: | + | [[Category: Neau, D B]] |
| - | [[Category: | + | [[Category: Pierce, A D]] |
| - | [[Category: | + | [[Category: Raman, E P]] |
| - | [[Category: Weber, D | + | [[Category: Toth, E A]] |
| + | [[Category: Varney, K M]] | ||
| + | [[Category: Weber, D J]] | ||
| + | [[Category: Wilder, P T]] | ||
| + | [[Category: Calcium binding]] | ||
| + | [[Category: Covalent inhibitor]] | ||
| + | [[Category: Malignant melanoma]] | ||
| + | [[Category: Metal binding protein-inhibitor complex]] | ||
Revision as of 16:58, 20 January 2016
Crystal Structure of Calcium-loaded S100B bound to SBi4225
| |||||||||||
Categories: Alasady, M J | Ansari, M I | Bezawada, P | Cavalier, M C | Coop, A | MacKerell, A D | McKnight, L E | Neau, D B | Pierce, A D | Raman, E P | Toth, E A | Varney, K M | Weber, D J | Wilder, P T | Calcium binding | Covalent inhibitor | Malignant melanoma | Metal binding protein-inhibitor complex
